AC
NUVB icon

Armistice Capital’s Nuvation Bio NUVB Stock Holding History

Armistice Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
2,000,000
+264,000
+15% +$1.29M 0.14% 100
2026
Q1 		$7.45M Buy
1,736,000
+472,263
+37% +$2.63M 0.13% 104
2025
Q4 		$11.3M Sell
1,263,737
-1,032,263
-45% -$6.39M 0.13% 97
2025
Q3 		$8.5M Buy
2,296,000
+1,796,000
+359% +$4.89M 0.13% 91
2025
Q2 		$975K Buy
+500,000
New +$1.04M 0.02% 151

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Armistice Capital's NUVB Position: Q2 2026 in Review

Armistice Capital increased its Nuvation Bio (NUVB) stake by 15% in Q2 2026, buying an estimated $1.29M and bringing the position to 2,000,000 shares worth $11.4M. The position accounts for 0.14% of the portfolio, ranked #100.

Armistice Capital first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Armistice Capital held 2,000,000 shares of Nuvation Bio worth $11.4M as of Q2 2026.
  • Armistice Capital bought 264,000 Nuvation Bio shares in Q2 2026, an estimated $1.29M.
  • Nuvation Bio made up 0.14% of Armistice Capital's portfolio in Q2 2026, its #100 holding.
  • Armistice Capital first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.